Skip to content
January 27, 2026
Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Primary Menu
Articles
Portfolios
Rakesh Jhunjhunwala Latest Portfolio
Dolly Khanna Latest Portfolio, Holdings, Wiki, News | December 2023
Research Reports
Stocks Talk
Top Stock Picks 2024 | Live Portfolio Tracker
Light/Dark Button
Search for:
Subscribe
Home
DOWNLOADS
DOWNLOADS
You may have missed
investments
Radico Khaitan’s revenues are expected to grow at CAGR of 19% over FY25-28E. Buy for target price of ₹3710 (25% upside): ICICI Securities
January 26, 2026
0
investments
Tatva Chintan Pharma Chem is sustaining improving revenue and profitability trajectory. Buy for target price of ₹1955 (41% upside): ICICI Securities
January 25, 2026
0
investments
Alivus Life Sciences is a compelling bet in the APIs space with strong execution prowess and a healthy balance sheet. Buy for target price of ₹1190 (32% upside): ICICI Direct
January 24, 2026
0
investments
APL Apollo Tubes valuation still looks attractive for long-term investors. Buy for target price of ₹2491 (26.3% upside): SBI Securities
January 23, 2026
0
investments
ITC Hotels’ growth momentum to sustain on back of favourable industry tailwind. Buy for target price of ₹240 (33% upside): ICICI Direct
January 22, 2026
0
investments
ITC Hotels has a healthy pipeline of hotels across owned and managed portfolio. Buy for target price of ₹235 (30.9% upside): JMFICS
January 21, 2026
0